Background: The eukaryotic release factor 3 (eRF3) has been shown to affect both tubulin and actin cytoskeleton, suggesting a role in cytoskeleton assembly, mitotic spindle formation and chromosome segregation. Also, direct interactions between eRF3 and subunits of the cytosolic chaperonin CCT have been described. Moreover, both eRF3a and CCT subunits have been described to be up-regulated in cancer tissues. Our aim was to evaluate the hypothesis that eRF3 expression levels are correlated with the expression of genes encoding proteins involved in the tubulin folding pathways. Methods: Relative expression levels of eRF1, eRF3a/ GSPT1, PFDN4, CCT2, CCT4, and TBCA genes in tumour samples relative to their adjacent normal tissues were investigated using real time-polymerase chain reaction in 20 gastric cancer patients. Results: The expression levels of eRF3a/GSPT1 were not correlated with the expression levels of the other genes studied. However, significant correlations were detected between the other genes, both within intestinal and diffuse type tumours. Conclusions: eRF3a/GSPT1 expression at the mRNA level is independent from both cell translation rates and from the expression of the genes involved in tubulin-folding pathways. The differences in the patterns of expression of the genes studied support the hypothesis of genetically independent pathways in the origin of intestinal and diffuse type gastric tumours. Clin Chem Lab Med 2009;47:427-31.
The eukaryotic release factor 3 (eRF3) has multi-functional properties in eukaryotic cells. The canonical role of eRF3 is to regulate protein synthesis as a GTPdependent stimulator of eRF1 in the termination step of translation (1) . After translation termination, the maturation process of some proteins, such as actins and tubulins, involves interaction of nascent chains with the heterohexameric protein prefoldin (PFDN). Its function is to deliver non-native target proteins to the eukaryotic cytosolic chaperonin for facilitated folding (2) . PFDN is a hetero-oligomeric complex assembled from six different proteins which interacts mainly with newly synthesised actins and tubulins, and protects them from aggregation while being transferred to the cytosolic chaperonin CCT (chaperonin containing TCP-1) (3). In mammalian cells, the CCT is a heterooligomeric complex with a double-ring-like structure showing eight-fold rotational symmetry of eight different subunits, encoded by a family of related genes designated from Ccta to Cctz-1. Each subunit of this complex recognises specific target proteins and they collectively modulate ATPase activity (4) . CCT has been shown to assist in the folding of actin and tubulin in the presence of ATP in vitro (5) and to bind newly synthesised actin and tubulin in vivo (6) . After release from the CCT complex in a quasi-native conformation, tubulins are accepted by cofactors following two different folding pathways: a-tubulin is captured by cofactor B (TBCB), while b-tubulin is captured by cofactor A (TBCA) (7). Then, cofactors E (TBCE) and D (TBCD) capture a-and b-tubulin, respectively. The two pathways converge and a-tubulin, b-tubulin, TBCE and TBCD form a super-complex. Cofactor C (TBCC) interacts with this complex and upon GTP hydrolysis assembled competent a/b-tubulin heterodimers are released (7) . A number of studies have demonstrated that the members of the tubulin folding pathway participate in the control of assembly and dynamics of cytoskeleton by controlling heterodimer maturation (8, 9 ).
An interaction between CCT subunits and eRF3 in human cells was first predicted using a theoretical model (10) , and experimentally confirmed by immunoprecipitation (11) . Using different organisms as study models, eRF3 has also been shown to affect both tubulin and actin cytoskeleton (12) (13) (14) (15) , suggesting a role in cytoskeleton assembly, mitotic spindle formation and chromosome segregation. The eRF3 protein is essential for G1 to S phase transition of the cell cycle (16, 17) . Interestingly, CCT expression levels also correlate with growth rates in mammalian cultured cells, and the expression of CCT is markedly upregulated in the early S phase of the cell cycle (9, 18). Gene-specific primers and a TaqMan probe labelled with 59FAM and 39MGB were used for all genes. Reactions were performed as described previously (19) .
In a previous study, we reported that eRF3a/GSPT1 is up-regulated in 70% of the intestinal histological type gastric tumours (19) . In addition, it was reported that the CCTa and CCTb subunits are up-regulated in hepatocelular carcinomas and in 83% of colonic tumours (20) . The identification of the genes and pathways that are altered in gastric tumourigenesis might contribute to improve diagnosis and therapy. In this study, we quantified the mRNA relative levels of expression of a number of components of the translation termination (eRF1 and eRF3a/GSPT1), protein folding (CCT2 and CCT4) and tubulin specific folding pathway (PFDN4 and TBCA) in gastric cancer patients, by real time-polymerase chain reaction using TaqMan probes (Table 1) . Our aim was to investigate if the expression of the genes encoding the components of these pathways are correlated and collectively contribute to tumourigenesis.
Freshly frozen samples of gastric tumours were obtained together with a sample from the adjacent non-cancerous tissue from 20 gastric cancer patients. Tissue samples were stored in RNAlater (Ambion, Austin, TX, USA) at -208C immediately after surgery until RNA extraction. The samples were verified to be gastric cancers by histological examination performed by a pathologist. Tumours were divided into two groups according to their histological types, which differed in epidemiology, aetiology, pathogenesis and behaviour (21): 10 intestinal type carcinomas (well differentiated cells, which retain cell cohesion allowing the formation of glandular structures with sharp margins) and 10 diffuse type carcinomas (containing small undifferentiated cells or small cell clusters with deceptive margins, which invade large areas of the stomach and can lead to early metastasis).
All the genes showed overexpression in a larger fraction of the intestinal type tumours (Figure 1 ). This is mostly observed in eRF3a/GSPT1 gene expression, which showed overexpression in 70% of the intestinal type tumours analysed, whereas only 10% of the diffuse type tumours overexpressed the gene (Table 2) . Regarding the genes coding for molecular chaperones, the CCT subunits were the most commonly upregulated, showing overexpression in more than 70% of the intestinal tumours. PFDN4 and TBCA were overexpressed in approximately 60% of the intestinal type samples. Within the diffuse type tumours, the mRNA levels of all the genes analysed were lower than in the intestinal tumours (Figure 1) .
The observed up-regulation of eRF3a/GSPT1 does not correlate with the expression of any of the other genes analysed (Table 3 ). In accordance with previous results (19) , eRF1 expression, which is the main factor in translation termination, did not correlate with eRF3a/GSPT1 mRNA levels, presumably because eRF3a is necessary to accomplish other roles in the cell apart from translation termination. Although not statistically significant, it is worth noting that correlations between eRF3a/GSPT1 and the other genes analysed are mostly negative correlations, especially in the intestinal type tumours (Table 3) .
It is known that the transfer of the polypeptide chain from the PFDN to the CCT complex is carried out through a mechanism that implies physical interaction between both complexes and that does not involve the release of the substrate (23) . Accordingly, our results revealed strong correlations between PFDN4 and CCT2 (rs1, p-0.001) in the intestinal tumours, and also between PFDN4 and CCT4 (rs0.885, p-0.01) in the diffuse tumours. Also, we observed strong correlations between CCT2 and TBCA in both types of tumours (rs0.967, p-0.001 in intestinal; rs0.909, p-0.001 in diffuse tumours), possibly as a consequence of functional interactions between them.
According to immunoprecipitation results, eRF3 interacts with specific subunits of the CCT complex and was found to be localised coincidently with CCTb Relative quantification of the mRNA levels of each gene (quantity of transcripts in tumour samples relative to normal tissues) was determined using the DDC T method (22) . Briefly, the amount of target was normalised to the endogenous reference gene (18S rRNA) and its expression in tumour samples was calculated relative to a calibrator (normal adjacent sample). Final results are expressed as n-fold difference in tumour expression relative to non-cancerous adjacent tissue. in particular sites of the cytosol (11) . Moreover, analysis of eRF3 and actin expression revealed that both proteins colocalise in the cell periphery (11) . However, in our study, eRF3a/GSPT1 mRNA levels of expression did not correlate with any of the CCT subunits analysed in gastric cancer samples. Our hypothesis of eRF3a/GSPT1 expression being correlated with the expression levels of CCT2 and CCT4 was not verified. Although eRF3a/GSPT1 expression at the mRNA level is likely to be independent from both cell translation rates and protein folding pathways, our results revealed up-regulated levels of expression of components of the translation termination and the protein folding pathway in gastric cancer tissues, mainly in the intestinal histological type tumours. These results are in good agreement with previously published studies (19, 20) and support the hypothesis of genetic independent pathways in the origin of intestinal and diffuse type gastric tumours. Understanding eRF3a/ GSPT1 gene regulation and its relation with cell cycle progression and cellular proliferation may have prognostic value and potential therapeutic applications.
